Navigation Links
Shengtai Pharmaceutical Schedules 2009 First Quarter Financial Results and Conference Call
Date:11/10/2008

WEIFANG, China, Nov. 10 /Xinhua-PRNewswire-FirstCall/ -- Shengtai Pharmaceutical, Inc. (OTC Bulletin Board: SGTI) ("Shengtai" or "the Company"), a leading manufacturer and distributor of high-quality, pharmaceutical grade glucose products in China, today announced that it will issue financial results for the three months ended September 30, 2008 after the close of the stock market on Thursday, November 13, 2008. Management will conduct a conference call on Friday, November 14, 2008 at 9:00 A.M. Eastern Standard Time to discuss these results. A question and answer session will follow management's presentation.

Mr. Qingtai Liu (Chief Executive Officer), Ms. Yiru Melody Shi (CFO), and Ms. Michelle Wang (Investor Relations Manager) will be the primary speakers on the call.

A live webcast of the conference call will be available on the Investor Relations page of Shengtai Pharmaceutical's web site at http://www.shengtaipharmaceutical.com . Please visit the Web site at least 15 minutes early to register for the webcast and download any necessary audio software.

To participate, please call the following numbers ten minutes before the call start time:

Phone Number: +1-877-407-8035 (North America)

Phone Number: +1-201-689-8035 (International)

A replay of the call will be available through Friday, November 21, 2008, at 11:59 P.M. Eastern Standard Time. For the replay, please call:

Phone Number: +1-877-660-6853 (North America)

Phone Number: +1-201-612-7415 (International)

Account Number: 286

Conference ID Number: 302820

About Shengtai Pharmaceutical, Inc.

Shengtai Pharmaceutical, Inc. through its wholly owned subsidiary, Shengtai Holding, Inc. (SHI), a New Jersey corporation, and the Chinese operating company of Weifang Shengtai Pharmaceutical Co., Ltd., is a leading manufacturer and supplier of pharmaceutical grade gluc
'/>"/>

SOURCE Shengtai Pharmaceutical, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Shengtai Pharmaceutical Completes Factory Improvements Resulting in Operational and Environmental Benefits
2. Shengtai Pharmaceutical Retains Grayling Global As Investor Relations Counsel
3. Shengtai Pharmaceutical, Inc. Appoints New CFO
4. Shengtai Pharmaceutical, Inc. Announces Conference Call to Discuss Second Quarter Results of Fiscal Year 2008
5. Potentia Pharmaceuticals Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
6. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
7. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
8. Simcere Pharmaceutical Group to Participate in Morgan Stanley Seventh Annual Asia Pacific Summit 2008
9. Critical Pharmaceuticals Raise GBP650K
10. WellSpring Pharmaceutical Corp. Announces Hire of Wayne Miller as Vice President, Sales & Marketing, Consumer Brands
11. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... iCardiac now provides services to three out of... Rochester, NY (PRWEB) Decembe... leader in advanced cardiac core lab services and ...aceutical company has selected iCardiac as a prefe...ll provide Highly Automated QT(sm) and Dynamic QT ...
(Date:11/30/2009)...NG OF PRUSSIA, Pa., Nov. 30 Cadie...izing in interactive marketing services and solut...the launch of its HATCH Consulting services ...ing strategic experts across a range of emerging a...onsulting team is committed to guiding companies a...
(Date:11/30/2009)...RDAM, November 30 Biopharmaceutica...irst patients have been enrolled in its,multinatio... study is,designed to show reduction in transplant...an allogeneic stem cell transplantation with a mis...tients eligible for an allogeneic,stem cell transp...
(Date:11/30/2009)... PDS, a leader in providing smart and efficient...Pajama Pathology®, evolutionizing work-from-ho...d standard’ software used by 8 of the Top 10...lsquo;cost per slide’ basis. , ...0, 2009 -- PDS has announced another evolution in ...
Breaking Biology Technology:Another Top Five Pharmaceutical Company Selects iCardiac as Preferred Provider of ECG Core Lab Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 2Pajama Pathology -- the New Wave of Preclinical Pathology Embraced by PDS 3
...el Discussion on Technologies That Will Change the...Each Other , , PISCATAWAY, N.J., March 10 IEEE, ..., today spotlighted seven technologies it believes...humans interact with machines, the world and each ... 10 March 2009 at the New Yorker Hotel in New York...
...AI ratio now available with VAP Cholesterol Test a...10 Atherotech, Inc., a cardio-diagnostic company,...(apoAI) to its VAP(R) Cholesterol Test. The VAP (V...esterol test that routinely reports apoAI, apoB, a...of this new marker, the VAP Test now reports apoAI...
...if., March 10 Frost & Sullivan recognizes Bio...p; Sullivan Award for Growth Strategy Leadership o...sis of the most significant drug-discovery innovat... leaders. BioTrove, a privately held company speci...nt technologies, has gained significant traction w...
Other Biology Technology:IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 2IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 3IEEE Celebrates Its 125th Anniversary Presenting Emerging, World Changing Technologies During Its 'Embracing Human Technology Interactions' Media Event 4Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test 2Atherotech Announces Addition of ApoAI Heart Disease, Diabetes Risk Marker to VAP(R) Test 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 2Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 3Frost & Sullivan Lauds BioTrove for Providing Research-Enabling Life Sciences and Drug Discovery Technologies 4
(Date:11/30/2009)... , , CLEMSON Clemson University researchers Ron ...Environmental Protection Agency grant to study the...ations located deep below the earth,s surface. , ... fuels believed to be the leading cause of global ... most promising alternatives for reducing emission...
(Date:11/30/2009)... , This release is available in German . ,... Collaborative Research Centres as of 1 January 20...t Grants Committee in Bonn. The new centres will i...132 million. In addition, 20 percent overhead fund...ach project. The centres, research topics range fr...
(Date:11/30/2009)... , The Editors of The Journal of Experimental Bi...in from Centre National de la Recherche Scientifiq...s is the winner of this year,s JEB Outstanding P...f an outstanding achievement and is intended to en...e JEB Editor-in-Chief, and adds that ,we truly a...
Breaking Biology News(10 mins):DFG approves funding for 17 new collaborative research centers 2DFG approves funding for 17 new collaborative research centers 3DFG approves funding for 17 new collaborative research centers 4DFG approves funding for 17 new collaborative research centers 5DFG approves funding for 17 new collaborative research centers 6DFG approves funding for 17 new collaborative research centers 7DFG approves funding for 17 new collaborative research centers 8DFG approves funding for 17 new collaborative research centers 9French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 1New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 2New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 3New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 4New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 5New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 6New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 7New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 8New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 9New Data Show CIMZIA 28R 29 28certolizumab pegol 29 Provides Sustained and Significant Symptom Improvement in Moderate to Severe Crohns Patients 5696 10BIO key 28R 29 International Exhibiting at AABB TXPO 10528 1BIO key 28R 29 International Exhibiting at AABB TXPO 10528 2Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 1Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 2Mayo Clinic study shows people with heart devices can digest advanced diagnostic technology safely 60087 3
... It is well known that animals use song as a way o...t gibbons have developed an unusual way of scaring...ogists at the University of St Andrews discovered ...que song as a natural defence to predators. Liter...se the song not just to warn their own group membe...
... Amsterdam, 21 September, 2006 - Elsevier is delig...ement to the journal Vaccine: HPV Vaccines and Scr...special monograph provides a comprehensive and inv... health educators, policy decision makers, industr...he arrival of the Human Papillomavirus (HPV) vacci...
... Before you request a paternity test, spend a few ... just give you the answer you,re looking for. Acc...versity of Tromso, Norway, the human eye color ref...attern of inheritance. Their studies, published t...y and Sociobiology, show that blue-eyed men find b...
Other Biology News:Singing for survival 2Singing for survival 3Blue eyes -- A clue to paternity 2
...s ideal for developing single and multi-analyte as...m contains the new, improved, and user friendly IS...n specific templates for commercial or home-made m...phing and data regression capabilities; the intern...
GeneSwitch-CHO Cell Line from Invitrogen
...ancements when used as directed, The AmpliCruz ...gned to amplify the desired signal detected by Wes... proteins with low expression., Membrane Enhanc... to blocking the membrane; 1x solution; 250 ml, ...
Silencer CellReady siRNA Transfection Optimization Kit from Ambion
Biology Products: